YD Bio Limited Reports 1H Results with Revenue Up 325%

Seeking Alpha··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

YD Bio Limited reported unaudited financial results for the six months ended June 30, 2026, showing revenue of $0.85 million, a 325.0% increase year-over-year. The company achieved net income of $6.7 million, compared to a net loss of $1.9 million in the same period last year. As of June 30, 2026, cash stood at $2,662,004, down from $6,007,615 at the end of 2025.

Impact on assets 1

Biotech & Genomic Medicine▲
YD Bio Ltd
YDES
▲ PositiveCapitalrelevance

Revenue up 325% and swing to net income of $6.7M from a loss.